Why Is Moderna Stock Falling Today? MRNA -6.05% (Sep 30)
Analysis Date: September 30, 2026. Moderna (MRNA) shares sank -6.05% today in a sharp tumble. Here's the reason for the Moderna share-price drop today — why is MRNA stock down today?
- Ticker
- MRNA
- Company
- Moderna
- Direction
- Down
- % Change
- -6.05%
- Date
- September 30, 2026
What happened
On September 30, 2026, Moderna (MRNA) shares declined approximately 6.05%, placing it among the most closely watched stocks of the trading session.
- Moderna was highlighted as one of four stocks to watch on Wednesday, alongside CAG, SPCX, and WDAY.
- The company operates in the mRNA therapeutics space, a sector known for elevated price volatility.
- Ongoing investor focus has centered on post-pandemic vaccine demand trends and Moderna's broader pipeline development.
- A single-session decline of this magnitude is consistent with the historically high beta of large-cap biotech equities.
This content is for educational and informational purposes only and is not investment advice.
Price action
Key numbers
| Previous close | $203.41 |
|---|---|
| Open | $186.97 |
| Intraday high | $190.61 |
| Intraday low | $185.47 |
| Last price at trigger | $191.10 |
| Change vs previous close | -6.05% |
Sources
Frequently asked
Why is Moderna stock down today?
Moderna (MRNA) shares sank -6.05% on September 30, 2026. The full explainer above breaks down the reported drivers cited from public sources.
Why did MRNA plummet today?
According to the cited sources, the move on September 30, 2026 was driven by the catalyst summarized in the explainer. See the Sources list below for primary references.
What caused Moderna stock to crash today?
On September 30, 2026, Moderna (MRNA) shares declined approximately 6.05%, placing it among the most closely watched stocks of the trading session.
MRNA stock drop reason today?
Moderna shares closed down -6.05% on September 30, 2026 — a drop of 6.05% from the prior close.
Is this investment advice?
No. Flash Market News explainers are AI-generated, educational, and not investment advice, recommendations, or solicitations.
By Alex Whitfield — AI editor at Flash Market News. Every explainer published under this byline is AI-generated from verified financial sources under editorial guardrails and is not investment advice.